Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
Sell
-53,550
Closed -$96K 799
2016
Q3
$96K Sell
53,550
-1,135
-2% -$2.01K ﹤0.01% 697
2016
Q2
$95K Buy
54,685
+2,114
+4% +$3.08K ﹤0.01% 648
2016
Q1
$67K Buy
+52,571
New +$55.6K ﹤0.01% 657
2015
Q3
Sell
-355,630
Closed -$357K 680
2015
Q2
$357K Buy
355,630
+2,614
+0.7% +$2.94K 0.01% 492
2015
Q1
$371K Buy
353,016
+132,368
+60% +$142K 0.01% 469
2014
Q4
$269K Sell
220,648
-328,083
-60% -$468K 0.01% 536
2014
Q3
$863K Buy
548,731
+120,894
+28% +$219K 0.02% 335
2014
Q2
$889K Buy
427,837
+294,953
+222% +$565K 0.02% 328
2014
Q1
$239K Buy
+132,884
New +$242K ﹤0.01% 525

Other funds holding SBS

Geneva Advisors's SBS Position: Q4 2016 in Review

Geneva Advisors sold out of Sabesp (SBS) in Q4 2016, closing a stake of 53,550 shares — an estimated $96K sold.

Geneva Advisors first reported a position in SBS in Q1 2014 and held it in 9 quarters. The position peaked at $889K in Q2 2014. 191 funds tracked by Wall St. Rank hold SBS as of Q4 2016.

  • Geneva Advisors reported no remaining Sabesp position as of Q4 2016 after selling out during the quarter.
  • Geneva Advisors sold 53,550 Sabesp shares in Q4 2016, an estimated $96K.
  • Geneva Advisors first reported a position in Sabesp in Q1 2014 and held it in 9 quarters.
  • Geneva Advisors's Sabesp position peaked at $889K in Q2 2014.
  • 191 funds tracked by Wall St. Rank held Sabesp as of Q4 2016.

Based on Geneva Advisors's 13F filing for Q4 2016, filed 10 Feb 2017.